Cardiovascular disease incidence rates: a study using routinely collected health data.

IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Cardio-oncology Pub Date : 2023-11-15 DOI:10.1186/s40959-023-00189-8
Johanna Ramroth, Rebecca Shakir, Sarah C Darby, David J Cutter, Valerie Kuan
{"title":"Cardiovascular disease incidence rates: a study using routinely collected health data.","authors":"Johanna Ramroth, Rebecca Shakir, Sarah C Darby, David J Cutter, Valerie Kuan","doi":"10.1186/s40959-023-00189-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is substantial evidence that systemic anticancer therapies and radiotherapy can increase the long-term risk of cardiovascular disease (CVD). Optimal management decisions for cancer patients therefore need to take into account the likely risks from a proposed treatment option, as well as its likely benefits. For CVD, the magnitude of the risk depends on the incidence of the disease in the general population to which the patient belongs, including variation with age and sex, as well as on the treatment option under consideration. The aim of this paper is to provide estimates of CVD incidence rates in the general population of England for use in cardio-oncology and in other relevant clinical, research and health policy contexts.</p><p><strong>Methods: </strong>We studied a population-based representative cohort, consisting of 2,633,472 individuals, derived by electronic linkage of records from primary care with those of admitted-patient care in England during April 1, 2010, to April 1, 2015. From 38 individual CVDs available via the linked dataset we identified five relevant categories of CVD whose risk may be increased by cancer treatments: four of heart disease and one of stroke.</p><p><strong>Results: </strong>We calculated incidence rates by age-group and sex for all relevant CVD categories combined, for the four relevant categories of heart disease combined, and for the five relevant CVD categories separately. We present separate incidence rates for all 38 individual CVDs available via the linked dataset. We also illustrate how our data can be used to estimate absolute CVD risks in a range of people with Hodgkin lymphoma treated with chemotherapy and radiotherapy.</p><p><strong>Conclusions: </strong>Our results provide population-based CVD incidence rates for a variety of uses, including the estimation of absolute risks of CVD from cancer treatments, thus helping patients and clinicians to make appropriate individualized cancer treatment decisions. Graphical Abstract: Cardiovascular incidence rates for use in cardio-oncology and elsewhere: A presentation of age- and sex-specific cardiovascular disease (CVD) incidence rates for use in calculation of absolute cardiovascular risks of cancer treatments, and in other clinical, research and health policy contexts. Abbreviations - CVD: cardiovascular disease; y: years.</p>","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":"9 1","pages":"41"},"PeriodicalIF":3.2000,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647140/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardio-oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40959-023-00189-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is substantial evidence that systemic anticancer therapies and radiotherapy can increase the long-term risk of cardiovascular disease (CVD). Optimal management decisions for cancer patients therefore need to take into account the likely risks from a proposed treatment option, as well as its likely benefits. For CVD, the magnitude of the risk depends on the incidence of the disease in the general population to which the patient belongs, including variation with age and sex, as well as on the treatment option under consideration. The aim of this paper is to provide estimates of CVD incidence rates in the general population of England for use in cardio-oncology and in other relevant clinical, research and health policy contexts.

Methods: We studied a population-based representative cohort, consisting of 2,633,472 individuals, derived by electronic linkage of records from primary care with those of admitted-patient care in England during April 1, 2010, to April 1, 2015. From 38 individual CVDs available via the linked dataset we identified five relevant categories of CVD whose risk may be increased by cancer treatments: four of heart disease and one of stroke.

Results: We calculated incidence rates by age-group and sex for all relevant CVD categories combined, for the four relevant categories of heart disease combined, and for the five relevant CVD categories separately. We present separate incidence rates for all 38 individual CVDs available via the linked dataset. We also illustrate how our data can be used to estimate absolute CVD risks in a range of people with Hodgkin lymphoma treated with chemotherapy and radiotherapy.

Conclusions: Our results provide population-based CVD incidence rates for a variety of uses, including the estimation of absolute risks of CVD from cancer treatments, thus helping patients and clinicians to make appropriate individualized cancer treatment decisions. Graphical Abstract: Cardiovascular incidence rates for use in cardio-oncology and elsewhere: A presentation of age- and sex-specific cardiovascular disease (CVD) incidence rates for use in calculation of absolute cardiovascular risks of cancer treatments, and in other clinical, research and health policy contexts. Abbreviations - CVD: cardiovascular disease; y: years.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心血管疾病发病率:一项使用常规收集的健康数据的研究。
背景:有大量证据表明,全身抗癌治疗和放疗可增加心血管疾病(CVD)的长期风险。因此,对癌症患者的最佳管理决策需要考虑到拟议的治疗方案可能带来的风险,以及可能带来的益处。对于心血管疾病,风险的大小取决于该疾病在患者所属的一般人群中的发病率,包括年龄和性别的差异,以及正在考虑的治疗方案。本文的目的是提供英国普通人群心血管疾病发病率的估计,用于心脏肿瘤学和其他相关的临床、研究和卫生政策背景。方法:我们研究了一个以人群为基础的代表性队列,由2,633,472人组成,通过2010年4月1日至2015年4月1日期间英国初级保健和住院患者护理的电子链接记录得出。从通过关联数据集获得的38个个体心血管疾病中,我们确定了五种相关的心血管疾病,其风险可能因癌症治疗而增加:四种心脏病和一种中风。结果:我们按年龄组和性别计算了所有相关心血管疾病类别的发病率,四种相关心脏病类别的发病率,以及五种相关心血管疾病类别的发病率。我们通过关联数据集提供了所有38种个体心血管疾病的单独发病率。我们还说明了我们的数据如何用于估计一系列接受化疗和放疗的霍奇金淋巴瘤患者的绝对心血管疾病风险。结论:我们的研究结果为多种用途提供了基于人群的心血管疾病发病率,包括估计癌症治疗引起的心血管疾病的绝对风险,从而帮助患者和临床医生做出适当的个体化癌症治疗决策。图表摘要:心血管肿瘤学和其他领域的心血管发病率:年龄和性别特异性心血管疾病(CVD)发病率的介绍,用于计算癌症治疗的绝对心血管风险,以及其他临床、研究和卫生政策背景。缩写- CVD:心血管疾病;y:年。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardio-oncology
Cardio-oncology Medicine-Cardiology and Cardiovascular Medicine
CiteScore
5.00
自引率
3.00%
发文量
17
审稿时长
7 weeks
期刊最新文献
A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2). Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort. Sternotomy and extracorporal circulation for fulminant Budd-Chiari syndrome due to leiomyosarcoma of the inferior vena cava. Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis. Cardiac arrhythmias during and after thoracic irradiation for malignancies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1